Aseptic Manufacturing of Parenteral Drug Products

Aseptic fill/finish is a crucial step in biopharmaceutical manufacturing, as it refers to the last step before a parenteral drug is packaged and ultimately delivered to the patient. More specifically, it is the process by which biopharmaceutical manufacturing companies transfer a filtered sterile drug product through a filling needle into an aseptic vial. If the drug is not sufficiently stable as a liquid formulation, lyophilization can be an important part of this process to keep the drug product as a lyophile and enhance shelf life.

The need for reliable, sterile pharmaceutical manufacturing processes for parenteral drug products is paramount to deliver much-needed vaccines and other injected, infused, and implanted drugs to people worldwide. Indeed, market research suggests that the global sterile injectables market will grow 11% annually through 2024 (ZionMarket Research, Jan. 2020).

In this important white paper, the fill/finish experts at Piramal Pharma Solutions’ Lexington, Kentucky site provide insights into key components of aseptic manufacturing of parenteral drug products, including:

  • Preventing cross contamination
  • Best-in-class lyopihilzation strategies
  • Stringent clean room standards
  • Mobile/modular processing
  • Single-use disposable systems
  • Sterilization and sanitation

Don’t miss out – Download your copy today!

Request Free!